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An extracellular layer of exopolysaccharides (EPS) covers the surface of some
Bifidobacterium animalis subsp. lactis strains, which could be of relevance for
its probiotic performance. In order to understand the functional characteristics of
B. animalis subsp. lactis, two isogenic strains that differ in their EPS-producing
phenotype, due to a single mutation in the gene Balat_1410, were studied. By means
of a double crossover recombination strategy, successfully used for the first time
in bifidobacteria, Balat_1410 in the type strain B. animalis subsp. lactis DSM10140
was replaced by a mutated gene containing a non-synonymous mutation previously
associated with the appearance of a mucoid-ropy phenotype. Nuclear magnetic
resonance and SEC-MALS analyses showed that the novel strain harboring the mutation
acquired a ropy phenotype, due to the production of a high molecular weight (HMW)-
EPS that is not produced in the wild-type strain. Fluorescence labeling of both
strains with two fluorescent proteins, m-Cherry and Green Fluorescent Protein, was
achieved by expressing the corresponding genes under the control of a native selected
promoter (the elongation factor Tu promoter). Remarkably, qualitative and quantitative
fluorescence analyses demonstrated that the ropy strain displays a lower capability to
adhere to human intestinal epithelial cells. In addition, the presence of the HMW-EPS
reduced the capability of the producing strain to form biofilms upon three different abiotic
surfaces. This work also highlights the fact that different EPS confer variable functional
characteristics to the bifidobacterial surface, which may be relevant for the performance
of B. animalis subsp. lactis as a probiotic. The construction of molecular tools allowing
the functional characterization of surface structures in next generation probiotics is still
a challenging issue that deserves further attention, given the relevant role that such
molecules must play in the interaction with the host.
Keywords: Bifidobacterium, exopolysaccharide, gene replacement, fluorescent proteins, NMR, SEC-MALS,
biofilms
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INTRODUCTION
The definition of a probiotic, proposed in 2001 by FAO/WHO,
states that is “live microorganisms which when administered
in adequate amounts confer a health benefit on the host.” The
most commonly commercialized probiotics are some species
from Bifidobacterium and Lactobacillus genera that have been
accepted as safe due to their long history of use and they
are often delivered into food formulations (Hill et al., 2014).
Nowadays, it is becoming more evident that certain intestinal
commensal microorganisms could be beneficial to correct
microbial dysbioses that have been related with some health
disorders; however, they have not been used to promote health
yet and, in case they will be applied in this context, they
would be treated as novel drugs more than food supplements.
These microorganisms can be considered as “next generation
probiotics” (NGP) and they are termed as “live biotherapeutic
products” (LBP) in the new regulatory framework of the Food
and Drug Administration (FDA) of United States of America
(O’Toole et al., 2017). Some of the proposed NGP belong to
genera Akkermansia, Bacteroides, and Faecalibacterium.
Orally delivered probiotics establish the main contact
point with the host at the intestinal mucosa level; in this
location, the probiotic-microbiota-cell interplay will drive
positive physiological benefits. Despite vast research efforts
made into the mechanisms behind the beneficial effects, the
manner of probiotic action still remains unclear (Gareau et al.,
2010; Wan et al., 2015). The (transitory) contact between
bacteria and intestinal epithelial cells might be relevant to
initiate this intercellular dialog; the surface microbial associated
molecular patterns (MAMPs) interacting with the host pattern
recognition receptors (PRR) are involved in triggering the
cellular response (Lebeer et al., 2010b; Westermann et al.,
2016). One of the most external layers covering the bacterial
surface is constituted by exopolysaccharides (EPS), which are
carbohydrate polymers whose genetic determinants are present
in intestinal bacteria, including most species of the genus
Bifidobacterium (Ferrario et al., 2016). In fact, some of the
beneficial properties attributable to the producing bifidobacteria
have been associated with their EPS and their physical-chemical
characteristics (Hidalgo-Cantabrana et al., 2014, 2016; Schiavi
et al., 2016). Additionally, it has been proven that EPS produced
by some NGP, such as Faecalibacterium prausnitzii, also has anti-
inflammatory properties in vivo, thus this bacterium is being
proposed as therapeutic agent to treat intestinal inflammatory
processes (Rossi et al., 2015).
The development of tools allowing the study of the
mechanisms of action, either for well recognized probiotics or
NGP, is essential in order to choose those strains which are more
valuable for each target population and health benefit. One of
the approaches is the use of vectors containing different labeling
systems; those applied to lactic acid bacteria and bifidobacteria
have recently been reviewed (Landete et al., 2016). A luciferase-
based reporter system was developed to monitor the performance
of Bifidobacterium breve UCC2003 under in vivo conditions
(Cronin et al., 2008). Different fluorescent proteins have been
successfully used as well to label bifidobacteria. In this way,
B. breve, B. longum subsp. Longum, and B. bifidum were labeled
with cyan fluorescent protein (CFP), green fluorescent protein
(GFP), yellow fluorescent protein (YFP) or mCherry under
the promoter of the gap gene (Pgap) of B. bifidum (Grimm
et al., 2014). Additionally, a GFP fluorescent protein containing
a flavin-mono-nucleotide-based cofactor (evoglow-Pp1), which
emits fluorescence in the presence/absence of oxygen, was
included in a vector under control of the elongation factor Tu
(Ptuf from B. longum) that replicates in B. longum and B. breve
(Landete et al., 2014). This system, which supposes an advantage
to study bifidobacteria in strict anaerobic conditions, was latterly
validated under the control of other promoters (Montenegro-
Rodríguez et al., 2015).
Bifidobacterium animalis subsp. lactis is one of the most
widely used probiotics and there are several human intervention
studies supporting its beneficial effects (Tojo et al., 2014).
From an industrial point of view, it is one of the most robust
bifidobacterial species which facilitates its inclusion in foods
or food supplements (Bogsan et al., 2014). The aims pursued
in the current work were: (i) to obtain an EPS-producing
variant by means of a double crossover marker-less strategy,
which produces a chromosomally stable new variant, (ii) the
construction of EPS-producing B. animalis subsp. lactis strains
harboring fluorescent proteins, which have not been reported
in literature to date, and (iii) the demonstration that different
EPS have an influence on the interaction of the producing
strain with biotic and abiotic surfaces. To achieve these goals,
a model of B. animalis subsp. lactis strains, which produced
EPS with different physical-chemical characteristics, was initially
used. This model was previously developed to demonstrate that
a single mutation in the gene Balat_1410, coding for a protein
involved in the elongation of the polymer chain, was directly
related to a higher abundance of the high molecular weight
(HMW)-EPS fraction (about 106 Da) that conferred a ropy-
mucoid phenotype to the producing strain (Hidalgo-Cantabrana
et al., 2015). Indeed, strains producing HMW-EPS are able to
attenuate the immune response (López et al., 2012) and they
have been proposed for their application in reducing intestinal
inflammatory states (Hidalgo-Cantabrana et al., 2016).
MATERIALS AND METHODS
Bifidobacteria Strains, Plasmids and
Culture Conditions
The B. animalis subsp. lactis and Escherichia coli strains, as
well as the plasmids and oligonucleotides used in this study,
are listed in Table 1. E. coli DH11S (InvitrogenTM, Thermo-
Fisher Scientific Inc., Waltham, MA, United States) was grown
in Luria-Bertani (LB) broth at 37◦C under shaking conditions
(200 rpm). Bifidobacterial strains were cultivated in MRSc
[MRS (Biokar Diagnostics, Beauvais, Francia) supplemented with
0.25% L-cysteine-HCl (Sigma-Chemical Co., St. Louis, MO,
United States)] at 37◦C under anaerobic conditions (80% N2, 10%
CO2, 10% H2) in a MG500 chamber (Don Whitley Scientific,
West Yorkshire, United Kingdom). Bacterial cultures and
competent cells were prepared under standardized conditions
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TABLE 1 | Bacterial strains, plasmids, and oligonucleotide primers used in this study.
Strains Description Reference
E. coli DH11S mcrA1(mrr-hsdRMS-mcrBC) 1(lac-proAB) 1(rec1398) deoR rpsL
srl-thi-F’ proAB+ lacIqZ1M15
Invitrogen
B. animalis subsp. lactis
DSM10140T Type strain, Plasmid free, EPS+, no ropy phenotype DSMZ collection
(yogurt isolated)
IPLA-R1 Plasmid free, EPS+, ropy-mucoid phenotype IPLA collection (bile-salt
adapted)




DSM10140 mutant obtained after gene integration of
Balat_1410S89L, EPS+, ropy-mucoid phenotype
This work
DSM10140-mCherry DSM10140 harboring pCAS-mCherry This work
DSM10140-GFP DSM10140 harboring pCAS- GFP This work
S89L-mCherry DSM10140-Balat_1410S89L harboring pCAS-mCherry This work
S89L-GFP DSM10140-Balat_1410S89L harboring pCAS- GFP This work
Plasmids Description Reference






pJL74 containing Balat_1410S89L together with the upstream (3 kb)
and downstream (2.7 kb) regions
This work
pAM1a E. coli-Bifidobacterium cloning vector; Ampr Emr Alvarez-Martín et al.,
2008
pCAS-mCherry mCherry fluorescent protein gene fused to the elongation factor Tu
promoter (Ptuf ) of B. animalis subsp. lactis in pAM1
This work
pCAS- GFP GFP fluorescent protein gene fused to the elongation factor Tu
promoter (Ptuf ) of B. animalis subsp. lactis in pAM1
This work
Oligonucleotides Sequence (5′–3′) Reference
Balat_1410 -GR-Fb TATATAGGGCCCGTCACCTCGTCACCATGAGCb Hidalgo-Cantabrana
et al., 2015
Balat_1410 -GR-Rb TATATAAGATCTCCACGAGAGCACACGAAGAC Hidalgo-Cantabrana
et al., 2015
In-Balat_1410 -F GGTATGATGTGCAGATTCGGCTTC This work





PTu_Fb TATATAAAGCTTACATCCGTTACGAATCACGC This work
mCh_Rb TATATATCTAGATTATTACTTGTACAGCTCGTCC This work
GFP_Rb TATATATCTAGATTATTATTTGTATAGTTCATCC This work
PTu_mCh_Fc GTCCAGGAGGACAAAAACATATGGTGAGCAAGGGCGAGG This work
mCh_PTu_Rc CCTCGCCCTTGCTCACCATATGTTTTTGTCCTCCTGGAC This work
PTu_GFP_Fc GTCCAGGAGGACAAAAACATATGCGTAAAGGAGAAGAAC This work
GFP_PTu_Rc GTTCTTCTCCTTTACGCATATGTTTTTGTCCTCCTGGAC This work
aAmpr, Emr, and Spr, resistance to ampicillin, erythromycin, and spectinomycin, respectively. bRestriction enzyme sites are underlined. cComplementary sequences for
splicing overlap extension PCR are bold marked.
(Hidalgo-Cantabrana et al., 2015) and ampicillin (100 µg/ml),
spectinomycin (100 µg/ml) or erythromycin (2.5 µg/ml) were
added when required (Table 1).
Molecular Techniques
Isolation of Chromosomal and Plasmid DNA, and
Plasmid Manipulation
Chromosomal DNA from B. animalis subsp. lactis was
isolated using the GeneEluteTM Bacterial Genomic DNA
kit (Sigma–Aldrich, Dorset, United Kingdom). Plasmid DNA
was isolated from E. coli using the Qiagen Plasmid Midi kit
(Qiagen, Hilden, Germany), whereas the plasmid isolation
from recombinant bifidobacteria was performed by means
of the GeneEluteTM Plasmid Miniprep kit (Sigma–Aldrich).
Manufacturer’s recommendations were followed in both
cases. For bifidobacterial strains, lysozyme (9 mg/ml, Merck,
Darmstadt, Germany) and mutanolysin (5U, Sigma–Aldrich)
were added during the lysis step followed by incubation at 37◦C
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for 1 h. DNA concentration was measured in Gene5TM Teck3
Module (BioTek, Vermont, United States).
For plasmid constructions, PCRs were performed using
Platinum R© Pfx DNA Polymerase (InvitrogenTM). Digestions
and ligations were made with restriction endonucleases from
Takara (Takara Bio Group, Otsu, Japan) and with T4 DNA
ligase from InvitrogenTM, respectively. All reagents were used
according to the manufacturers’ instructions. PCR products
were checked by electrophoresis in TAE buffer [40 mM TRIS,
20 mM acetic acid, 1 mM EDTA (pH 8)] on 1% agarose gels
and then stained with ethidium bromide (0.5 µg/ml). DNA
purification from the agarose gels was performed using QIAquick
Gel Extraction Kit (QIAgene) and sequenced at Macrogen
Inc. (Seoul, South Korea). BLAST algorithm was used for
sequence similarity analysis. Finally, Eurx-Taq DNA Polymerase
from Roboklon GmbH (Berlin, Germany) was used to check
plasmid constructions in E. coli and plasmid integration in the
bifidobacterial chromosome.
Gene Replacement: Plasmid Construction and
Double Crossover Events
The chromosomal DNA from B. animalis subsp. lactis IPLA-R1
was used as a template for PCR amplification using the specific
primers Balat_1410-GR-F/R (Table 1) for the construction of
the plasmid for gene replacement. These primers amplify 7.1 kb
which contain the Balat_1410S89L gene (Hidalgo-Cantabrana
et al., 2015) and its flanking regions: upstream (3 kb) and
downstream (2.7 kb). The PCR product was digested with
ApaI and BglII and cloned into pJL74 previously digested
with the same enzymes. Ligation was performed overnight at
16◦C and the ligation mixture was purified and transformed
into E. coli DH11S electrocompetent cells. The resulting
plasmid was named pCHC3 (pJL-upst/Balat_1410S89L/dst) and
was introduced into B. animalis subsp. lactis DSM10140-
1Balat_1410 electrocompetent cells prepared as previously
reported (Hidalgo-Cantabrana et al., 2015). After transformation,
bifidobacterial cells were immediately recovered in 2 ml of
MRSc and incubated at 37◦C under anaerobic conditions for
4–6 h before plating onto the same agar-medium containing
spectinomycin (100 µg/ml). Plates were then incubated for 48
to 72 h at 37◦C in anaerobic conditions. Transformants were
checked for plasmid integration into the chromosome (single
crossover) by PCR using the specific primers In-Balat_1410-
F/R and Spec-F/R (Table 1). At this point of the experiment,
two of the checked colonies acquired the visually recognizable
ropy phenotype (having the integrated plasmid) and they were
selected to be grown in 10 ml MRSc without antibiotic. Two
subcultures (per day) were made for 5 days to force the loss of
the plasmid (second crossover) and, afterward, these bacterial
cultures were plated onto agar-MRSc without antibiotics for
48 h. Several colonies were picked up and each of them was
grown in agar-MRSc, with and without spectinomycin, to select
the non-antibiotic resistant colonies due to the loss of the
plasmid. These colonies were checked by PCR using the specific
primers In-Balat_1410-F/R and Spec-F/R to analyze the presence
of Balat_1410S89L and the absence of spectynomicin-resistance
genes into the chromosome; besides, the ropy phenotype,
associated with the presence of Balat_1410S89L, was useful for
the selection of the right colonies. Thus, one strain with a
ropy character, then putatively carrying the Balat_1410S89L gene,
and being sensitive to spectynomicin, was selected and named
DSM10140-Balat_1410S89L, or S89L in its abbreviated form
(Table 1). To confirm its genetic background, the chromosomal
DNA from S89L was obtained and an inner fragment (1 kb) of
Balat_1410S89L gene, containing the mutation (C to T transition)
responsible for the ropy trait (Hidalgo-Cantabrana et al., 2015),
was amplified using the In-Balat_1410-F/R primers. The genetic
background of the eps cluster surrounding the insertion and
the complete insert was also checked with a set of primers that
amplify 1 kb overlapping fragments (data not shown). All these
PCR products were sequenced at Macrogen Inc. to confirm the
absence of undesirable mutations.
Strain Labeling Using Fluorescence Plasmids
Plasmids harboring fluorescent proteins under the control of the
elongation factor Tu promoter from B. animalis subsp. lactis were
constructed using splicing overlap extension PCR strategy to fuse
the DNA sequences (Vallejo et al., 1994). The “elongation factor
Tu” promoter was amplified from the chromosomal DNA of
DSM10140 strain using the specific primers PTu_F/mCh_PTu_R
(Table 1). The gene encoding mCherry fluorescent protein was
amplified from the pVG-mCherry plasmid (Grimm et al., 2014)
with specific primers PTu_mCh_F/mCh_R. The PCR products
that have complementary tails, between each other, were size-
checked in 1% agarose gel. Then, splicing overlap extension
PCR was performed to fuse both fragments. The same protocol
was followed to fuse the elongation factor Tu promoter to GFP
gene: the Tu promoter was amplified using specific primers
PTu_F/GFP_PTu_R, and GFP gene was obtained from the
pVG-GFP plasmid (Grimm et al., 2014) using specific primers
PTu_GFP_F/GFP_R. Fused DNA fragments were checked by
electrophoresis and purified from agarose gels. The fused DNA
fragments were digested with HindIII and XbaI at 37◦C for
3 h, as well as the plasmid pAM1 (Alvarez-Martín et al., 2008)
which was also dephosphorylated. Digestions were also purified
from agarose gels and used to perform overnight ligations at
4◦C. Electrocompetent E. coli DH11S cells were transformed
with the ligation mixtures and selection of clones was performed
by adding ampicillin (100 µg/ml) to the culture medium. The
resulting plasmids were named pCAS-mCherry and pCAS-GFP
(Table 1). The strains B. animalis subsp. lactis DSM10140 and
S89L were transformed with these plasmids and four fluorescent
clones were selected by adding erythromycin (2.5 µg/ml) to
the culture medium; the recombinant strains were named as





The fluorescent bifidobacterial strains were grown onto the
surface of agar-MRSc containing erythromycin, for 3 days
at 37◦C under anaerobic conditions. The fluorescence of the
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colonies was checked in the Typhoon 9400 scanner (GE
Healthcare, Biosciences, Uppsala, Sweden). GFP was excited with
blue laser (488 nm) and emission was detected with 526 nm band-
pass filter. In the case of mCherry, excitation was performed with
red laser (633 nm) and emission was acquired with 580 nm band-
pass filter. These plates were scanned at a resolution of 100 µm
pixel size.
Fluorescence Microscopy and Confocal Scanning
Laser Microscopy (CSLM)
To visualize the bifidobacteria expressing the fluorescent
proteins, overnight grown cultures (in MRSc + erythromycin)
were washed, placed on a slide covered with coverslip No.1
(0.13–0.16 mm thick). These preparations were observed with
the Leica DMi8 inverted microscope (Leica Microsystems GmbH,
Heidelberg, Germany), using a 100× oil immersion objective.
The FITC filter cube (excitation 480/40, emission 527/30) and
RHOD filter cube (excitation 546/10, emission 585/40) were used
for visualization of the bifidobacteria harboring GFP or mCherry
proteins, respectively.
Fluorescent (mCherry) bifidobacteria adhered on the top of
the intestinal cell line HT29 or into glass slides (as will be
described next) were visualized with the Leica TCS AOBS SP8
X confocal inverted microscope [External Service Unit (ESU) of
the University of Oviedo, Asturias, Spain]. To visualize DAPI
fluorochrom, samples were excited at 405 nm, by a blue-violet
laser diode, whereas to detect the mCherry they were excited
at 587 nm by a white light laser. Z-stacks of HT29 monolayers
or bifidobacterial biofilms upon glass µ-slides were acquired
with a 63×/1.4 oil objective. When needed, a 2.50 optical zoom
was used to acquire images of detailed regions. Image captures
were reordered and processed with the Leica Application Suit X
software (version 1.8.1.13759, Leica).
Fluorescence Spectrometry
Fluorescence quantification was performed with overnight
cultures of the four fluorescent bifidobacteria, as well as the two
parental DSM10140 and S89L strains used as negative controls.
Cells were washed with PBS and standardized to an equal
OD600 nm; additionally, they were plated in the corresponding
(with and without antibiotic) agar-MRSc media. Afterward, the
standardized bacterial suspensions were 10-fold concentrated
and from them, serial (half) dilutions were prepared in PBS.
96-well LumitrackTM 600 white polystyrene plates (VWR,
Radnor, PA, United States) were filled with 200 µl (per well)
of each bifidobacterial dilution. Fluorescence was measured
on the Cary Eclipse (Varian Ibérica, S.A. Madrid, Spain)
fluorescence spectrometer using the following conditions:
470 nm excitation/525 nm emission, for GFP quantification, and
585 nm excitation/610 nm emission for mCherry quantification.
The corresponding fluorescence background, determined from
the control samples (parental, non-labeled bifidobacterial
suspensions), was subtracted from data obtained for the
fluorescent strains. This experiment was performed with three
biological replicates. Finally, linear regression equations between
the fluorescence emitted and the number of bacteria (Log
CFU/ml) were calculated, as well as the corresponding coefficient
of determination (R2) that shows how well the data fits to the
linear regression.
Flow Cytometry
Fluorescence of bifidobacterial suspensions, obtained as
previously described, were also quantified in the Cytomics FC500
(Beckman Coulter, Barcelona, Spain) located in the ESU from
the University of Oviedo. A fix acquisition time of 90 s with “hi”
acquisition speed was used. The 488 nm laser was applied for
the excitation of both fluorochromes and the selection of the
bifidobacterial population was made by means of FSC log/SSC
log (size/complexity). This gate was used to plot the FL1 (for GFP
detection) vs. FL3 (for mCherry detection) histograms; the filters
525/40 and 620/30 were used for the detectors FL1 and FL3,
respectively. The absence of auto-fluorescence was checked in the
corresponding non-labeled bacteria (Supplementary Figure S1).
In the labeled strains the recorded fluorescence was compensated
to avoid the overlapping of both fluorochromes. Finally, serial
dilutions of the samples (from 1/2 to 1/100) were measured
and the linear regression equations between the “fluorescence
emitted” (total number of events multiplied by the mean
fluorescence intensity) and the number of bacteria (CFU/ml); the
R2 coefficients were calculated as well (Supplementary Figure S2).
Chemical Analysis of Purified EPS
EPS Purification
The EPS from strains DSM10140, S89L and IPLA-R1 were
isolated from the bifidobacterial biomass collected with water
from the surface of agar-MRSc plates as previously described
(Ruas-Madiedo et al., 2010). Each bacterial suspension was mixed
with 1 volume of 2 M NaOH and kept overnight at room
temperature under mild shaking. Bacteria were eliminated by
centrifugation and the EPS from the supernatant was precipitated
with two volumes of chilled absolute ethanol for 48 h at
4◦C. Precipitated sediment was collected with ultra-pure water
and dialyzed against water, using dialysis tubes of 12–14 kDa
molecular mass cut off (Sigma), at 4◦C for 3 days with a daily
change of water. Finally, each dialyzed sample was freeze-dried
in order to obtain the crude-EPS material from each strain. To
isolate the HMW EPS-fraction from strains S89L and IPLA-R1,
the crude-EPS (25 mg) was dissolved in ultra-pure water (10 ml),
dialysed (against water, for 72 h at 4◦C) using Spectra/Por Float-
A-Lyser 100 kDa MWCO tubes (Sigma), and the content of these
dialyzed tubes was freeze-dried (Leivers et al., 2011).
SEC-MALLS Analysis
The molar mass distribution of the crude-EPS and HMW-
EPS, as well the quantification of the relative amount of
the different size-fractions, were performed by means of size
exclusion chromatography (SEC); a chromatographic system
(Waters, Milford, MA, United States) coupled in series with a
refractive index (RI) detector (Waters) and with a multi-angle
laser light scattering detection (MALLS, Dawn Heleos II, Wyatt
Europe GmbH, Dembach, Germany) was used as previously
described (Nikolic et al., 2012).
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NMR Analysis
The HMW-EPS fractions were analyzed by nuclear magnetic
resonance (NMR) at the facilities of the University of Seville
(Seville, Spain). A sample of 10 mg was deuterium-exchanged
several times by freeze-drying from D2O and then examined
in solution (10 mg/750 mL of 99.96% D2O, Sigma–Aldrich).
Spectra were recorded on a Bruker AV500 spectrometer (Bruker
BioSciences, Madrid, Spain) operating at 500.13 MHz (1H).
Chemical shifts were given in ppm, using the HDO signal
(4.31 ppm at 343 K) as reference (Gottlieb et al., 1997). The 2D
heteronuclear one-bond proton-carbon correlation experiment
was registered in the 1H-detection mode via single-quantum
coherence (HSQC). A data matrix of 256 × 1K points was used
to digitize a spectral width of 5208 in F2 and 22522 Hz in F1. 13C
decoupling was achieved by the GARP scheme. Squared-cosine-
bell functions were applied in both dimensions, and zero-filling
was used to expand the data to 1K× 1K.
Adhesion to HT29
The intestinal epithelial cell line HT29 (ECACC 91072201,
European Collection of Cell Cultures, Salisbury, United
Kingdom) was used to test the adhesion capability of the
fluorescence-labeled and non-labeled bifidobacterial strains;
B. animalis subsp lactis BB-12 was used as reference strain.
HT29 was maintained under standard conditions using McCoy’s
medium (MM, Sigma) supplemented with 10% fetal bovine
serum (Sigma) and with a mixture of antibiotics (50 µg/ml
penicillin, 50 µg/ml streptomycin, 50 µg/ml gentamicin and
1.25 µg/ml amphotericin B, Sigma). The adhesion experiments
were performed upon 11-day old HT29 monolayers grown
in microtiter plates. Bifidobacterial suspensions, prepared in
MM (without antibiotics), were added to each well at ratio 10:1
(bifidobacteria: HT29) and incubated for 1 h at 37◦C/5% CO2
(Nikolic et al., 2012). For the non-labeled strain the number of
bacteria added and bacteria adhered was determined by plating
on agar-MRSc and the adhesion percentage was calculated as the
ratio between the bacteria adhered with respect to the bacteria
added (Nikolic et al., 2012). For the fluorescence-labeled bacteria,
the fluorescence was measured by means of flow cytometry, as
previously described, and values of absolute fluorescence were
used to present the adhesion results. In addition, experiments
of competition between the “fluorescence-labeled, ropy” strain
and the “non-labeled, non-ropy” strain (or “fluorescence-labeled,
non-ropy” vs. “non-labeled, ropy”) for adhesion to HT29 were
carried out; in this case, both bacteria were added in equal
amounts to the cell line (10:1, ratio bacteria: HT29) and the
absolute fluorescence was measured.
Bifidobacterial Biofilm Formation upon
Abiotic Surfaces
The capability of the ropy and non-ropy EPS-producing
bifidobacterial strains to form biofilms was determined using
different procedures and abiotic surfaces. A method, based on
impedance measurement, recently described by Gutiérrez et al.
(2016) to monitor in real time the formation of bacterial biofilms
was used. In short, the real time cell analyzer (RTCA) equipment
xCelligence RTCA-DP (ACEA Bioscience Inc., San Diego, CA,
United States) was introduced in an incubator, at 37◦C with
5% CO2, at least 2 h before the experiments. Bifidobacterial
cultures were washed twice with PBS to prepare standardized
suspensions in fresh MRSc (∼109 cfu/ml) which were placed in
the wells (100 µl/well) of specific E-plates (ACEA Bioscience Inc.)
coated with gold-microelectrodes that are able to transmit the
impedance signal. The RTCA software 2.0 (ACEA Bioscience)
was used for data collection and the biofilm formation was
followed for 46 h, using three biological replicates for each
strain; finally, the wells were stained with crystal violet, as will
be described next. Biofilms were also formed upon polystyrene
plates (96-well microplates Nunc, Thermo-Fisher Scientific
Inc.), upon microscope cover glasses (No. 1, 18 mm diameter,
Marienfeld GmbH, Lauda-Königshofen, Germany) previously
sterilized by autoclaving (121◦C, 20 min) which were placed into
6-well microplates (Thermo Fisher Scientific Inc.), and upon the
surface of µ-slide-2-well glass bottom (Ibidi GmbH, Martinsried,
Germany). After 24-h incubation at 37◦C in anaerobic chamber,
these biofilms were also stained with crystal violet. Additionally,
the fluorescence-labeled bifidobacterial biofilms (incubated in
darkness) formed upon cover glasses were visualized under the
epifluorescence microscope and those formed upon the surface
of µ-slide-2-well glass bottom were detected with the CSLM.
Crystal Violet Staining
The end-point crystal violet method was used to quantify the
bifidobacterial biofilm formation upon the three abiotic surfaces
used (Gutiérrez et al., 2016). In brief, supernatants from different
abiotic-material wells were removed and biofilms washed twice
with PBS, dried for 15 min at room temperature and stained
with a solution (0.1% w/v) of crystal violet for 15 min. Then,
biofilms were gently washed with water, de-stained with a
solution (33%) of acetic acid for at least 15 min and, finally,
the absorbance of the supernatants was measured at 595 nm in
a Microplate Benchmark Plus (Bio-Rad, Hercules, CA, United
States) spectrophotometer.
Statistical Analysis
The statistical package IBM SPSS Statistics for Windows
Version 22.0 (IBM Corp., Armonk, NY, United States) was
used to assess differences among strains by means of one-way
ANOVA followed, when needed, by SNK (Student-Newman–
Keuls, p < 0.05) mean comparison test. The legend of each figure
indicates the analysis performed. Finally, the R2 coefficients, that
reflect the adjustment to linear regression equations between
different parameters, were calculated.
RESULTS AND DISCUSSION
Generation of a Ropy Strain with a
Non-synonymous Mutation in the Gene
Balat_1410
In a previous work, an isogenic mutant derived from the
type strain B. animalis subsp. lactis DSM10140 by removing
the gene Balat_1410, using a knockout mutation system based
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on the integrative plasmid pJL74, was constructed (Hidalgo-
Cantabrana et al., 2015). Our first aim in the present study
was to reintroduce into the genome of B. animalis subsp. lactis
DSM10140-1Balat_1410 a mutated Balat_1410 gene containing
a non-synonymous, single nucleotide mutation previously
associated with the appearance of a mucoid-ropy phenotype
in the strain DSM10140-1Balat_1410-pAM1-Balat_1410S89L
(Hidalgo-Cantabrana et al., 2015). To do that, a double-crossover
marker-less strategy previously used for the deletion of the
gene, was followed. The strain DSM10140-1Balat_1410 was
transformed with the plasmid pCHC3 (Table 1) containing a
fragment of approximately 7 kb amplified from the genome of the
strain IPLA-R1 (Table 1), that includes the regions immediately
located upstream and downstream of the gene Balat_1410 as
well as the mutated gene Balat_1410S89L between those regions.
Gene integration was achieved as previously described (Hidalgo-
Cantabrana et al., 2015), resulting in B. animalis subsp. lactis
DSM10140-Balat_1410S89L (abbreviated as S89L), a strain that
has exactly the same genetic background as B. animalis subsp.
lactis DSM10140 which underwent a gene replacement that
resulted in a C to T transition in the gene Balat_1410 at
position 266, causing a codon change in position 89 (a serine
is substituted by a leucine). Although there are several works
that have reported gene deletion and interruption systems in
bifidobacteria, including B. breve (Ruiz et al., 2012), B. longum
(Fukuda et al., 2011; Hirayama et al., 2012) and B. animalis subsp.
lactis (Arigoni and Delley, 2008; Hidalgo-Cantabrana et al.,
2015), to our knowledge this is the first report of a successful gene
replacement strategy in bifidobacteria. Due to the lack of genetic
tools to introduce specific point mutations in bifidobacterial
genomes, our methodology represents a suitable alternative to
overcome this limitation.
Analysis of EPS Synthesized by the
Recombinant Ropy Strain
In the EPS synthesized by the two ropy strains B. animalis
subsp. lactis IPLA-R1 (parental) and S89L (recombinant) the
HMW-EPS fraction (about 1 × 106 Da) was present in a higher
proportion than in the non-ropy DSM10140 (parental) strain
(Figure 1A). It should be noticed that the polymer material
purified from the three strains, with the procedures used in
this study, is the cell-associated EPS but not that liberated into
the medium. Previously, the production of the HMW-EPS was
correlated with the occurrence of the mucoid-ropy appearance
in a recombinant strain harboring the mutated gene in a multi-
copy plasmid (Hidalgo-Cantabrana et al., 2015); thus, currently
this finding was reinforced with the acquisition of the ropy
phenotype in the novel S89L having the single mutation stabilized
into the chromosome. After purification of the HMW-EPS
fraction from polymers synthesized by IPLA-R1 and S89L strains,
one- and two-dimensional NMR analyses revealed an identical
FIGURE 1 | Physical-chemical analysis of EPS isolated from three B. animalis subsp. lactis strains. SEC-MALLS analysis of the EPS-DSM10140, EPS-S89L and
EPS-IPLA-R1 showing the molecular weight (Mw) and relative abundance of the high molecular weight (HMW) fraction in each polymer (A). 1H-NMR (500 MHz,
343 K) spectra (B) and 500-MHz1H-13C- HSQC spectra (C) of HMW-EPS purified from EPS-IPLA-R1 and EPS-S89L polymers.
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FIGURE 2 | Physical map of pCAS-GFP and pCAS-mCherry, in which the GFP and mCherry genes are located downstream from the elongation factor Tu promoter
(Ptuf ) from B. animalis subsp. lactis DSM10140 (A). Detection of fluorescence green (top) or red (bottom) colonies of B. animalis subsp. lactis DSM10140-GFP and
DSM10140-mCherry, respectively, using the Typhoon 9400 scanner fluorescence scanner (left hand photographs) and aspect of the colonies visualized with a
conventional camera (right hand photographs) (B). Fluorescent B. animalis subsp. lactis S89L, transformed with pCAS-GFP (top) and pCAS-mCherry (bottom),
visualized with the Leica DMi8 inverted microscope using a 100× oil immersion objective (C). Strain B. animalis subsp. lactis S89L-mCherry showing a colored pink
colony with a ropy phenotype denoted for the formation of a long, unbreakable filament (D).
chemical composition (Figures 1B,C). These physical-chemical
analyses undoubtedly prove that the gene replacement strategy
applied to obtain the recombinant S89L strain was successful
to introduce the mutation linked to the production of the
HMW-EPS. The structural repeating unit of the HMW-EPS was
already described for strain IPLA-R1 (Leivers et al., 2011); it
is an hexapolysaccharide with 50% rhamnose content, and it is
very similar to that reported for strain B. animalis subsp. lactis
LKM512 (Uemura and Matsumoto, 2014).
Expression of Fluorescent Proteins in
B. animalis subsp. lactis and
Fluorescence Detection
Bifidobacterium animalis subsp. lactis DSM10140 and S89L were
transformed with the plasmids pVG-GFP and pVG-mCherry,
containing the genes coding for the proteins GFP and mCherry,
respectively. It was reported that these plasmids were successfully
used for the fluorescent detection of B. longum, B. breve, and
B. bifidum strains, grown in similar conditions to those used
in our study (Grimm et al., 2014). However, no fluorescence
was detected in our B. animalis subsp. lactis strains using
fluorescence spectrometry techniques, suggesting that either the
genes are not expressed or the proteins do not emit fluorescence
under our experimental conditions. Since gene expression in the
plasmids pVG-GFP and pVG-mCherry is under the control of
the promoter of the glyceraldehyde-3-phosphate dehydrogenase
gene of B. bifidum (Pgap), a specific promoter of B. animalis
subsp. lactis was investigated which could be suitable to trigger
the expression of the GFP and mCherry genes in our strains.
Our previous work on bifidobacteria allowed us to depict a
detailed protein map of the most abundant cytoplasmic proteins
in their soluble proteome (Sánchez et al., 2005, 2007). Indeed,
one of the most abundant proteins in the soluble proteome
of some bifidobacteria is the elongation factor tu (the product
of the tuf gene; Sánchez et al., 2005; Wei et al., 2016).
Furthermore, previous reports have shown that the Ptuf of
B. longum is a suitable strong and constitutive promoter able
to trigger the expression of fluorescent proteins in B. longum
and B. breve (Landete et al., 2014). These previous findings
indicate that the tuf promoter could be a good candidate for
the expression of heterologous genes in B. animalis subsp.
lactis. With this in mind, the promoter of the glyceraldehyde-
3-phosphate dehydrogenase, originally present in the plasmids
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FIGURE 3 | Fluorescence quantification of GFP (the two left panels) and mCherry proteins (the two right panels) of the bifidobacterial strains harboring the
corresponding plasmids using the Cytomics FC500 flow cytometer; see Supplementary Figure S2 for correlation with bacterial enumeration in agar-MRSc (A). Linear
regression between the fluorescence emitted, recorded by the CaryEclipse fluorescence spectrometer, and the bacterial counts (Log CFU/ml) of seriated dilutions of
the fluorescent bifidobacterial suspensions; the coefficients of determination (R2), showing how well data fit to the regression line equations, are indicated in bold
letters (B).
pVG-GFP and pVG-mCherry, was replaced by the upstream
region of the tuf gene of B. animalis subsp. lactis DSM10140,
containing Ptuf , yielding the plasmids pCAS-mCherry and
pCAS-GFP (Table 1 and Figure 2A). These plasmids were
used to transform B. animalis subsp. lactis DSM10140 and
B. animalis subsp. lactis S89L; green and red fluorescence in the
resulting strains (DSM10140-mCherry, DSM10140-GFP, S89L-
mCherry and S89L-GFP) were detected by fluorescence scanning
(Figure 2B) and fluorescence microscopy (Figure 2C). The
ropy phenotype, denoted by the formation of a filament, was
detected in the strain S89L-mCherrey which also acquired a pink
color in the colony (Figure 2D). Furthermore, a quantitative
analysis of the fluorescently labeled bifidobacteria was performed
using flow cytometry (Figure 3A), and the fluorescence signal
was correlated with bacterial counts by a linear regression
analysis (Supplementary Figure S2). Our results showed that
the fluorescence quantification of the strains labeled with the
two fluorescent proteins correlate with the bacterial counts in
agar plates. The coefficients of determination (R2) obtained in
these analysis were in all cases higher than 0.95, indicating
the suitability of our approach to quantify fluorescently labeled
bifidobacterial populations in a range of 2 log count units
(Figure 3A and Supplementary Figure S2). Very good fits to
the linear regression were also obtained in a range of 3 log
count units when the fluorescence quantification was carried
out using spectrometric techniques (Figure 3B). Previous works
have shown that other species, such as B. longum, B. bifidum,
and B. breve, can be fluorescently labeled with a variety of
proteins, including GFP, m-Cherry, Yellow Fluorescent proteins
and Cyan Fluorescent proteins (Grimm et al., 2014; Landete
et al., 2014). However, it is worth highlighting that, to the best of
our knowledge, this is the first report describing the fluorescent
labeling of B. animalis subsp. lactis, which opens new possibilities
to track the functional properties of this Bifidobacterium under
in vitro and in vivo conditions.
Regarding the stability of the fluorescence emission of GFP
and mCherry, the fluorescence signal of GFP was quite unstable
compared with that of m-Cherry. Once the cell growth was
stopped, the cells were not able to emit fluorescence for longer
than 1 h, independently of the technique used to measure the
GFP fluorescence. A quick decrease in the fluorescence in the
two B. animalis subsp. lactis strains analyzed was observed.
However, m-Cherry fluorescence was more intense and stable for
longer periods of time (a significant decrease of the fluorescent
signal after 24 h at RT was not observed) (data not shown).
Therefore, the strains labeled with m-Cherry were selected to
perform the experiments described in the following sections of
this work.
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FIGURE 4 | Adhesion to the intestinal cell line HT29 of four B. animalis subsp. lactis strains: DSM10140 and Bb12 display a non-ropy phenotype and S89L and
IPLA-R1 display a ropy phenotype. Bars that do not share a common letter are statistically (p < 0.05) different (A). Visualization of DSM10140-mCherry (a, b, and c)
and S89L-mCherry (d, e, and f) strains adhered to HT29 using the TCS SPE confocal module of the Leica DMi8 inverted microscope (bars 10 µm). The nucleus was
DAPI-stained in blue (excited at 405 nm), the green color corresponds with the auto-fluorescence emitted by cytoplasmic molecules of the cell line, and the
fluorescent bifidobacteria were detected in red (excited at 561 nm). The bottom photographs (c and f) represent a rotated 3D-image obtained from the Z- projection
(10-XY slides, thickness about 13–15 µm) showing the integrity of the HT29 monolayer covered by a “grass” of fluorescent B. animalis subsp. lactis strains (B).
Adhesion to HT29 of strains DSM10140-mCherry and S89L-mCherry (red bars) quantified by means of flow cytometry; statistical difference between both strains are
indicated with asterisks (p < 0.01). The pink bars show the adhesion of the fluorescent strains in competition with the non-fluorescent counterpart strains (C).
Application of Fluorescence Labeling to
Assess the Role of Ropy EPS in the
Adhesion to HT29
In the last consensus statement in the probiotics field revised
in 2014, it was considered that the FAO/WHO Guidelines
proposed in 2002 (Food, and Agricultural Organization of the
United Nations, and World Health Organization [FAO/WHO],
2002) still provide a useful approach to search for and validate
probiotic candidates (Hill et al., 2014). Among the in vitro
tests carried out to study new strains, the capability to
adhere to mucus and/or intestinal epithelial cells is extensively
analyzed before undertaking in vivo studies. In this study,
conventional (culturing) techniques have been used to test
the adhesion to the human intestinal cell line HT29 of the
recombinant B. animalis subsp. lactis S89L strain in comparison
with their isogenic parental strains. The ropy S89L and
IPLA-R1 strains, both synthesizing in higher abundance the
HMW-EPS, adhered significantly less to HT29 than DSM10140
and Bb12 (a probiotic reference) strains (Figure 4A). This
result was contrary to that obtained in a previous work
with the recombinant (ropy) DSM10140-1Balat_1410-pAM1-
Balat_1410S89L strain harboring the mutated Balat_1410 gene
in the multicopy plasmid pAM1 (Hidalgo-Cantabrana et al.,
2015). In fact, the three recombinant strains carrying pAM1
plasmid showed higher adhesion values (above 3%) to HT29
than the values obtained in the current work for the better
adherent (around 1%) strains (DSM10140 and Bb12). Thus,
in order to clarify this, apparently, contradictory result, the
fluorescently labeled strains were used to address their capability
to adhere to HT29 by means of different techniques and using
the new experimental models in which there is a single copy of
Balat_1410 (or Balat_1410S89L) in the chromosome. The CSLM
visualization corroborated that the ropy, HMW-EPS producing
S89L-mCherry strain adhered to HT29 in lower proportions
than the non-ropy DSM10140-mCherry strain (Figure 4B).
Similarly, the quantitative flow cytometry technique showed
about a fivefold reduction (p < 0.05) in the adhesion of the first
strain with respect to the second (Figure 4C). Additionally, the
simultaneous addition of a fluorescent strain in combination with
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its non-labeled counterpart (e.g., strain DSM10140-mCherry and
S89L) did not modify the adhesion capability of both fluorescent
ropy and non-ropy strains (Figure 4C); this indicates that
the higher abundance of the HMW-EPS did not represent a
disadvantage for in vitro competition to adhere to the epithelial
cell line. Thus results obtained in the current study support
the generalized finding that EPS of high molecular mass make
difficult the adhesion of the producing strain to the intestinal
epithelium because they could hinder the accessibility of other
molecules acting as adhesins (Lebeer et al., 2009; Nikolic et al.,
2012; Horn et al., 2014). However, the role of bacterial EPS
on the adhesion capability of the producing strain has not
been clearly established since it is highly dependent on the
producing strain, the intrinsic characteristics of the polymer,
as well as on the biological model of study used. As an
illustrative example, in vitro studies showed that the EPS
surrounding Lactobacillus rhamnosus GG reduced the adhesion
of the strain to the intestinal cell line Caco2 (Lebeer et al.,
2009) because the accessibility of the pili acting as strong
adhesin to enterocytes was hindered (Lebeer et al., 2012).
However, in vivo studies showed that this EPS forms a protective
shield against host-antimicrobial secreted factors which helps
the persistence of strain GG in the gut (Lebeer et al., 2010a).
Thus, production of EPS by L. rhamnosus GG is relevant to keep
an optimal performance, i.e., a balance between protection and
adhesion.
Role of Ropy EPS in the Biofilm
Formation upon Abiotic Surfaces
Another important role that EPS synthesized by probiotic
bacteria could play in the gut ecosystem is the capability of
reducing the activity of pathogens in the intestine, including
their adhesion to the intestinal epithelium. This has been proved
with in vitro (Ksonzeková et al., 2016; Zivkovic et al., 2016)
as well as in vivo studies (Fanning et al., 2012; Chen et al.,
2014; Nácher-Vázquez et al., 2015) using different intestinal cell
lines and animal models, respectively. It was postulated that the
mechanism behind this EPS protection could be the formation of
a protective “biofilm-like” layer covering the intestinal epithelium
and, therefore, preventing the adhesion of the pathogen or its
toxins (Ruas-Madiedo et al., 2010; Fanning et al., 2012). Thus, to
test the biofilm-formation ability of our EPS-producing bacteria
different methodologies and abiotic surfaces were used as an
initial approach before demonstrating this capability in biotic
surfaces which, currently, is a challenging issue (Figure 5). The
recently developed impedance-based method to monitor in real
time the bacterial biofilm formation upon gold-microelectrodes
of RTCA E-plates (Gutiérrez et al., 2016) showed that the ropy
S89L strain presented a lower adhesion ability than the non-
ropy DSM10140 parental one during the incubation period
(Figure 5A). To discard any influence of the abiotic material on
the adhesion ability, 24 h-old biofilms were formed upon glass-
cover or polystyrene and compared with 46 h-old biofilms made
of RTCA E-plates; all biofilms were stained with crystal violet
and this method also supported the same tendency between both
strains (p < 0.05) regardless of the abiotic surface considered
FIGURE 5 | Monitoring in real time the formation of biofilms by strains
B. animalis subsp. lactis DSM10140 and S89L upon (gold-microelectrodes)
E-plates in the RTCA (real time cell analyzed) equipment (A). Biofilms formed
by the same strains in three abiotic surfaces and stained, at different
end-point times, with the crystal violet method; within each strain, bars that
do not share a common letter are significantly (p < 0.05) different (B).
(Figure 5B). However, statistical differences were noted when
the behavior of each strain in the three abiotic surfaces was
compared; for strain S89L the lowest biofilm formation capability
was upon gold and polystyrene, whereas strain DSM10140
showed better adherence to gold (Figure 5B). This variability
could be related to variations in the hydrophilic/hydrophobic
nature of both bacterial surfaces that could suppose variable
affinities for materials with different physical properties. In fact,
it has been proved that the polar and non-polar characteristics of
abiotic surfaces are involved in the differential capability to form
biofilms of some pathogens (Meira et al., 2012).
The visualization by epifluorescence microscopy of 24 h-old
biofilms formed with the fluorescent-labeled strains showed a
higher bacterial density on the glass covered with the non-ropy
DSM10140-mCherry strain, in comparison with the ropy S89L-
mCherry ones (Figure 6A); a quantitative test performed with
the same strains confirmed this difference (p < 0.05). Similarly,
when intact bifidobacterial biofilms formed upon µ-slides were
visualized with CSLM a very thin 3-D structure was detected only
for strain DSM10140-mCherry whereas only residual bacteria
remained attached for strain S89L-mCherry (Figure 6B). As far
as we could note, this is the first report showing the biofilm
formation by Bifidobacterium spp. and depending on the type
of polymer that is synthesized it could favor or prevent the
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FIGURE 6 | Detection of fluorescence-labeled bifidobacterial DSM10140-mCherry and S89L-mCherry strains upon glass covers using the epifluorescence
microscope (bar 5 µm) and crystal violet quantification of the biofilms formed upon the glass covers; bars that do not share a common letter are significantly
(p < 0.05) different (A). Rotated 3D-images obtained from the Z- projection (thickness about 2–4 µm) showing the biofilm formed by B. animalis subsp. lactis
DSM10140-mCherry upon glass µ-slides and the absence of biofilm by strain S89L-mCherry (B).
adhesion of the bifidobacteria to different abiotic surfaces. As it
was indicated above, the presence of a HMW-EPS fraction could
reduce the contact of other surface adhesins with the abiotic
surface, thus avoiding the biofilm formation.
Therefore, all approaches used showed a reduced capability of
the HMW-EPS-producing strains to form biofilms upon abiotic
surfaces, as was also observed in the biotic (HT29) surface.
Our observation confirms that previously reported with the high
molecular mass EPS synthesized by L. rhamnosus GG (38) and
L. johnsonii FI9785 (Dertli et al., 2015). The molecular weight
of the HMW-EPS synthesized by these lactobacilli as well as
our strain S89L was equal or higher than 1 × 106 Da; whereas,
the most abundant polymer fractions in the DSM10140 had
lower molecular weight (less than 3 × 104 Da). Therefore,
although it cannot be discarded that some specific EPS could
form a biofilm layer on the gut surface, other mechanisms
could be involved in the capability of EPS-producing bacteria
to counteract the adhesion of pathogens. In this regard, our
previous observations with polymers purified from lactobacilli
and bifidobacteria suggest that these polymers could also act as
analogs of the eukaryotic PRR for pathogens, i.e., having a “lectin-
like” activity, and therefore reducing their adhesion to the gut
mucosa (Ruas-Madiedo et al., 2006). In any case, the contribution
of EPS to counteracting microbial dysbiosis caused by infections
deserves future research (Reid et al., 2011).
To sum up, our results show that fluorescent labeling of
B. animalis subsp. lactis can be achieved by using green and
mCherry fluorescent proteins but that these genes need to be
under the control of a promoter from this species. It was
demonstrated that the introduction of Balat-1410 mutation into
the chromosome of parental DSM10140 strain was linked to
the production of a larger abundance of a HMW-EPS, which
in turn confers a ropy phenotype. Tagging bifidobacteria with
mCherry allowed us to determine that some relevant functional
characteristics of the strains, such as the adhesion to human
intestinal cells or the capacity to form biofilms, are associated
with the presence/absence of this ropy phenotype. The novel
recombinant strains obtained in this work are a valuable tool
to study the cross-talk mechanisms between bifidobacteria and
host cells, and can make possible the development of further
approaches to elucidate the role of these bacteria in complex
in vivo systems. Furthermore, similar methodological approaches
are required to demonstrate the functional properties of NGP
bacteria which must be used to decipher the role of surface
molecules involved in the beneficial properties attributable to
beneficial microorganisms.
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